XIENCE Implantation Followed By Short Dual Antiplatelet Therapy: 'The New Normal'? [0.03%]
XiENCE植入术后短期双抗治疗：“新常态”?
Niels Mr van der Sangen,Wouter J Kikkert,José Ps Henriques et al.
Niels Mr van der Sangen et al.
The XIENCE family of everolimus-eluting stents ranks among the most used and most widely studied drug-eluting stents worldwide. In patients at high bleeding risk undergoing non-complex percutaneous coronary intervention with these stents, a...
An Update on Drug-eluting Technology in Peripheral Arteries to Treat Peripheral Arterial Disease [0.03%]
外周动脉药物洗脱技术治疗外周动脉疾病进展
Leonardo Marques,Silke Hopf-Jensen,Michael Preiss et al.
Leonardo Marques et al.
For the treatment of peripheral arterial disease, drug-eluting technology is a widely accepted therapeutic option, with significant reduction in intimal hyperplasia and, consequently, use of target lesion revascularization. Nevertheless, th...
The HEP-COVID Trial [0.03%]
HEP-COVID试验
Alex C Spyropoulos
Alex C Spyropoulos
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Left Main Revascularisation [0.03%]
左主干血运重建的经皮冠状动脉介入治疗与冠脉旁路移植术对比研究
Timir Kumar Paul
Timir Kumar Paul
Management of Coronary Artery Disease in the Setting of Transcatheter Aortic Valve Replacement [0.03%]
经导管主动脉瓣置换术后的冠状动脉疾病的处理策略
Natraj Katta,J Dawn Abbott,Ankur Kalra et al.
Natraj Katta et al.
Aortic stenosis and coronary artery disease (CAD) frequently co-exist, as they share a common pathophysiology and risk factors. Due to lack of randomised controlled trials (RCTs) and exclusion of significant CAD in transcatheter aortic valv...
A Rare Case of Cor Triatriatum Sinister in Adulthood with Atypical Manifestation [0.03%]
成人冠状窦侧三房心的罕见病例报告及不典型表现分析
Thauler Alves de Oliveira,Renan Attílio Santos Marquiori
Thauler Alves de Oliveira
A 47-year-old man was admitted to the Santa Casa de Misericórdia Hospital in Belo Horizonte, Brazil, with recurrent signs and symptoms of tachycardia, palpitation and fatigue. During medical examination, an electrocardiogram and 24-hour Ho...
Cardiovascular Effects of COVID-19 - What Do We Know and Where Should We Go? [0.03%]
新冠肺炎的心血管影响：我们了解多少？未来研究方向何在？
Matthew Ryan,Ozan Demir,Kevin O&#x;Gallagher et al.
Matthew Ryan et al.
Amongst the many challenges of the global pandemic, understanding the effects of coronavirus disease 2019 (COVID-19) on the cardiovascular system has emerged as a key priority. Emerging data indicate possible roles for cardiac biomarkers an...
Comparison of Contemporary Drug-eluting Coronary Stents - Is Any Stent Better than the Others? [0.03%]
当代药物洗脱冠状动脉支架的比较——哪种支架更优？
William Parker,Javaid Iqbal
William Parker
Percutaneous coronary intervention (PCI) with implantation of a metallic drug-eluting stent (DES) is the mainstay of treatment in patients with significant coronary artery disease or acute coronary syndromes. DESs comprise a metallic platfo...
Fauve A Noordergraaf,Marco Alings
Fauve A Noordergraaf
Factor Xa (FXa) inhibitors are widely used for stroke prevention in patients with nonvalvular atrial fibrillation, and for the treatment and prevention of deep venous thrombosis and pulmonary embolism. Compared with warfarin, individual FXa...
Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity [0.03%]
天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值可作为冠状动脉局限性扩张及其严重程度的标志物
Danesh Soltani,Samira Jafari,Haleh Ashraf et al.
Danesh Soltani et al.
Background: Several studies have reported an association between elevated liver enzymes and increased risks for developing inflammatory diseases. The aim of our study was to examine how serum liver transaminases, as inexp...